Opioid Rehab Near You: MAT, Detox & Recovery Programs
Browse SAMHSA-listed opioid rehab programs across all 50 states — filter by MAT type (buprenorphine, methadone, naltrexone), level of care (OTP, OBOT, residential, IOP, telehealth), and insurance acceptance. MAT reduces opioid overdose deaths by more than 50% (NIDA), yet fewer than 20% of people with OUD receive it. Synthetic opioids (primarily fentanyl) drive ~75% of US opioid overdose deaths — CDC reports over 80,000 annually. After the 2023 MAT Act, any licensed prescriber can offer buprenorphine in office-based or telehealth settings.
Found 9,319 rehab centers specializing in opioid addiction across the United States.
Need Help Finding the Right Treatment Center?
Speak with a compassionate specialist now - 100% free & confidential
Find Opioid Treatment Centers Near You
Browse opioid treatment centers below. Filter by MAT availability, state, insurance, and level of care to find the right program for your recovery needs.
Showing 20 of 9319 results
Situated in Franklin, VA, the BHG Franklin Treatment Center specializes in outpatient services aimed at treating substance use disorders. This center offers outpatient treatment options that include methadone, buprenorphine, or naltrexone for both adult men and women, including individuals with histories of domestic or intimate partner violence. Employing proven strategies such as cognitive behavioral therapy, the Matrix Model, and motivational interviewing, the facility serves a diverse adult and young adult population. With an emphasis on personalized care and a nurturing atmosphere, the BHG Franklin Treatment Center is committed to supporting clients as they pursue their recovery journey.
BHG Bessemer Treatment Center, situated in Bessemer, AL, delivers outpatient treatment for substance abuse to both adults and young adults. This center specializes in addressing dual diagnoses, combining substance use issues with significant mental health conditions or emotional challenges. BHG Bessemer Treatment Center offers outpatient services utilizing methadone, buprenorphine, or naltrexone, alongside standard outpatient care. The facility also features specialized programs for active-duty military members, as well as tailored support for adult men and women. Emphasizing techniques such as brief intervention, motivational interviewing, and incentive-based strategies, this center commits to providing individualized care that meets each client's unique requirements. Individuals seeking thorough and customized addiction treatment will find BHG Bessemer Treatment Center to be an essential part of their recovery process.
Situated in Joplin, MO, BHG Joplin Treatment Center specializes in outpatient detox and substance abuse treatment for both adults and young adults. The center focuses on delivering tailored care for adult males, adult females, and clients involved in the criminal justice system. Utilizing various therapeutic methods, such as 12-step programs, anger management, and brief intervention strategies, this facility serves both male and female individuals aiming for complete addiction recovery. BHG Joplin Treatment Center emphasizes high-quality care and personalized treatment plans to assist clients in achieving their sobriety goals.
BHG Chesapeake South Treatment Center, located in Chesapeake, VA, specializes in detoxification and addiction treatment programs designed for adults and seniors. Prioritizing individualized support, this facility offers a range of options including intensive outpatient treatment, outpatient services, and outpatient detoxification programs. Utilizing proven methods such as 12-step facilitation, anger management, and brief intervention, the center effectively addresses various addiction challenges. BHG Chesapeake South Treatment Center serves both men and women, promoting a welcoming atmosphere for everyone. Clients can anticipate exceptional care crafted to meet their unique needs, establishing this center as a leading option for those in search of expert and tailored addiction recovery services.
BHG Denver Treatment Center, situated in Denver, Colorado, provides focused outpatient and intensive outpatient programs for individuals struggling with substance use. Tailored for adult men and women, the center also caters to clients with a history of trauma, offering bespoke support for diverse needs. Emphasizing evidence-based methodologies, BHG Denver Treatment Center employs strategies such as brief interventions, cognitive behavioral therapy, and community reinforcement with vouchers to promote successful recovery outcomes. Committed to delivering exceptional care, the facility assists adults and young adults from all backgrounds in their journey toward overcoming addiction.
Situated in Brainerd, MN, BHG Brainerd Treatment Center provides outpatient treatment for substance use, featuring options like methadone/buprenorphine and naltrexone. The center is proficient in various techniques, including brief intervention, cognitive behavioral therapy, and motivational interviewing. BHG Brainerd Treatment Center offers tailored programs for adult men, adult women, and pregnant or postpartum women. It serves both adults and young adults, accommodating clients of all genders. Committed to personalized care and evidence-based methods, this facility aims to deliver exceptional addiction treatment services in a nurturing and supportive atmosphere.
Methadone and buprenorphine are dispensed through outpatient treatment at BHG Colorado Springs Treatment Center in Colorado, which also treats co-occurring serious mental illness in adults and serious emotional disturbance in children. Programs serve pregnant and postpartum women, veterans, and forensic clients. Medicare, Medicaid, SAMHSA block grants, and government funding are accepted.
BHG Columbia TN Treatment Center is an outpatient opioid treatment program in Columbia, TN, offering methadone and buprenorphine along with outpatient detoxification. Adults of all ages are served. Medicare, Medicaid, TRICARE, SAMHSA block grants, and state-financed insurance are accepted, and sign language services are available.
BHG Davenport Treatment Center in Davenport, Iowa, provides regular and intensive outpatient care with buprenorphine treatment for opioid use disorder. Specialized programs serve adult women, pregnant and postpartum women, adult men, and clients with co-occurring mental and substance use disorders. Federal funding, Medicare, Medicaid, TRICARE, and private insurance are accepted.
Outpatient medication treatment with buprenorphine or naltrexone is provided at this Des Moines, Iowa treatment center, with regular outpatient substance use care for young adults, adults, and seniors. Medicare, Medicaid, TRICARE, state-financed insurance, and government funding are accepted, and sign language services are available for the deaf and hard of hearing.
Medication-assisted treatment with methadone or buprenorphine is the core service at BHG Fort Collins Treatment Center in Fort Collins, Colorado, delivered through outpatient and intensive outpatient programs. Services include tracks for adult women, adult men, criminal justice clients, and trauma survivors. Medicare, Medicaid, and TRICARE are accepted, and sign language services are available.
Medication treatment with methadone or buprenorphine is provided on an outpatient basis at this Fort Wayne, Indiana treatment center. Programs serve young adults, pregnant and postpartum women, seniors, veterans, military families, criminal justice clients, and people with co-occurring disorders or HIV or AIDS. Medicare, Medicaid, private insurance, and government funding are accepted, with sign language services.
BHG Hazard Treatment Center, situated in Hazard, KY, delivers a wide range of substance use treatment options tailored for both adults and young adults. The facility specializes in intensive outpatient therapy, standard outpatient services, as well as outpatient treatments using methadone, buprenorphine, or naltrexone. With a strong emphasis on 12-step programming, anger management, and brief therapeutic interventions, BHG Hazard Treatment Center effectively addresses various substance use disorders. The center also offers dedicated programs for active military personnel, adult men, and women, ensuring that it meets the needs of a diverse population. By providing personalized treatment plans, the center guarantees high-quality support for individuals on their path to addiction recovery.
BHG Huntsville Treatment Center in Huntsville, Alabama is an outpatient opioid treatment program using methadone and buprenorphine, with care for co-occurring serious mental illness. Medicare, Medicaid, private insurance, SAMHSA block grants, and self-pay are accepted.
BHG Jackson GA Treatment Center in Jackson, Georgia provides outpatient detoxification and medication treatment for opioid use disorder using methadone, buprenorphine, and naltrexone. Clients with co-occurring pain and substance use disorders are served. Medicare, Medicaid, private insurance, self-payment, and payment assistance are accepted.
Situated in Chesapeake, VA, BHG Chesapeake Treatment Center delivers extensive detox and substance abuse services for adults and elderly individuals. The facility offers customized programs including intensive outpatient, outpatient, and outpatient detoxification, all designed to meet the unique requirements of each client. BHG Chesapeake Treatment Center is proficient in 12-step methodologies, anger management, and brief intervention strategies, facilitating a tailored recovery experience. With an emphasis on personalized support, this center accommodates both men and women in need of compassionate addiction care. Opt for BHG Chesapeake Treatment Center for proven methodologies and a nurturing atmosphere on your journey to recovery.
BHG Clyde Treatment Center, situated in Clyde, NC, delivers extensive treatment options for adults and young adults facing substance use challenges. The facility features intensive outpatient programs along with various outpatient services, including methadone/buprenorphine or naltrexone treatments. Employing methods such as cognitive behavioral therapy, anger management, and the Matrix Model, the center customizes its programs to meet the unique needs of each person. Committed to high-quality care, BHG Clyde Treatment Center specializes in treatments for both men and women. Its mission is to support individuals in overcoming addiction and achieving sustainable recovery through personalized, evidence-driven strategies.
Nestled in Cullman, AL, BHG Cullman Treatment Center provides outpatient care for substance use disorders. Their approach emphasizes medication-assisted treatment using methadone, buprenorphine, or naltrexone. The center utilizes proven techniques, including cognitive behavioral therapy, the Matrix Model, and motivational interviewing, to deliver thorough support. BHG Cullman Treatment Center offers specialized programs for adult men, adult women, and expectant/new mothers, addressing a variety of requirements. They serve adult and young adult individuals of all genders, developing personalized treatment strategies for everyone. Discover effective substance use recovery and customized assistance at this dedicated facility.
BHG Jackson TN Treatment Center is an outpatient clinic in Jackson, Tennessee, offering methadone and buprenorphine for opioid use disorder, plus outpatient detoxification and co-occurring disorder treatment. It serves veterans, military families, and pregnant women, and accepts Medicare, Medicaid, TRICARE, and SAMHSA block grants.
BHG Kansas City North Treatment Center, situated in Kansas City, KS, delivers outpatient services for drug and alcohol detoxification and ongoing substance use disorder therapy, serving both adults and young adults. The center is equipped to provide tailored support to active military members, adult men, and adult women. Employing therapeutic modalities such as anger management, brief intervention strategies, and community reinforcement coupled with voucher incentives, the program prioritizes a personalized recovery journey. BHG Kansas City North Treatment Center welcomes both male and female individuals, fostering an inclusive atmosphere for healing. Clients can anticipate comprehensive addiction treatment services designed to meet their unique requirements.
Opioid Use Disorder (OUD): Key Facts
Classification
Opioid Use Disorder (OUD)
Prevalence
2.1 million adults with OUD in the US (SAMHSA)
Overdose deaths
80,000+ opioid overdose deaths/year in US (CDC)
Primary substances
Fentanyl, heroin, oxycodone, hydrocodone
Gold standard treatment
Medication-Assisted Treatment (MAT)
MAT effectiveness
Reduces overdose deaths by 50%+ (NIDA)
FDA-approved medications
Buprenorphine (Suboxone), Methadone, Naltrexone (Vivitrol)
Emergency reversal
Naloxone (Narcan)
Opioid Overdose Emergency: Know the Signs
An opioid overdose can kill within minutes. If you see these signs, act immediately:
Overdose warning signs
- Blue or purple lips and fingernails (cyanosis)
- Pinpoint (extremely small) pupils
- Slow, shallow, or stopped breathing
- Unresponsive to shouting or sternal rub
- Gurgling or choking sounds
- Limp body, pale or clammy skin
What to do
- Call 911 immediately — most states have Good Samaritan laws protecting callers
- Administer naloxone (Narcan) if available — nasal spray or injection
- Perform rescue breathing — one breath every 5 seconds
- Place in recovery position (on their side) to prevent choking
- Give a second dose of naloxone after 2-3 minutes if no response
- Stay until help arrives — naloxone wears off in 30-90 minutes
National Overdose Prevention Hotline: 911 | SAMHSA Helpline: 1-800-662-4357 (24/7, free, confidential)
What Is Opioid Use Disorder?
DSM-5 diagnostic criteria
Opioid Use Disorder (OUD) is a chronic, relapsing brain condition defined by the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). It is diagnosed when a person meets at least two of eleven criteria within a 12-month period, including: taking opioids in larger amounts or for longer than intended, persistent desire or unsuccessful efforts to cut down, spending excessive time obtaining or using opioids, cravings, failure to fulfill major obligations, continued use despite social or interpersonal problems, giving up important activities, use in physically hazardous situations, continued use despite physical or psychological problems, tolerance, and withdrawal.
Severity classification
OUD severity is classified based on the number of criteria met: mild (2-3 criteria), moderate (4-5 criteria), and severe (6 or more criteria). Severe OUD carries the highest risk of overdose death and typically requires the most intensive treatment, including medication-assisted treatment. Even mild OUD warrants professional intervention, as the disorder tends to progress without treatment.
Opioids vs. opiates
The term "opiates" refers specifically to natural compounds derived from the opium poppy (morphine, codeine). "Opioids" is the broader term that includes opiates plus semi-synthetic drugs (oxycodone, hydrocodone, heroin) and fully synthetic drugs (fentanyl, methadone, tramadol). All opioids bind to mu-opioid receptors in the brain, producing pain relief, euphoria, and respiratory depression — the mechanism that causes fatal overdoses.
The Opioid Epidemic: Fentanyl Crisis
Three waves of the opioid epidemic
The US opioid crisis has unfolded in three distinct waves. The first wave (1990s) was driven by aggressive marketing of prescription opioids — OxyContin, Vicodin, Percocet — leading doctors to overprescribe and millions of patients to develop dependence. The second wave (around 2010) saw a surge in heroin use as people with prescription opioid addiction shifted to cheaper, more accessible heroin. The third wave (2013-present) is defined by illicitly manufactured fentanyl and its analogs, which now account for the majority of opioid overdose deaths in the United States.
Why fentanyl changed everything
Fentanyl is a fully synthetic opioid that is 50-100 times more potent than morphine and approximately 50 times more potent than heroin. A lethal dose of fentanyl is just 2 milligrams — roughly the size of a few grains of salt. Because fentanyl is cheap to manufacture and extremely potent by weight, drug traffickers mix it into heroin, cocaine, methamphetamine, and counterfeit prescription pills. Many people who die from fentanyl overdoses did not know they were consuming it. Counterfeit pills made to look like oxycodone (M30), Xanax, or Adderall frequently contain lethal doses of fentanyl.
Current impact
According to the CDC, over 80,000 Americans die from opioid overdoses each year, with synthetic opioids (primarily illicit fentanyl) responsible for roughly 75% of those deaths. Opioid overdose is now the leading cause of accidental death for Americans under 50. The crisis affects every demographic, geographic region, and socioeconomic group in the country.
Opioid Withdrawal Timeline
Opioid withdrawal is intensely uncomfortable but rarely life-threatening on its own. The timeline varies depending on whether the person was using short-acting opioids (heroin, oxycodone, hydrocodone) or long-acting opioids (methadone, extended-release morphine).
Short-acting opioids (heroin, oxycodone)
- 6-12 hours: Onset of symptoms — anxiety, muscle aches, sweating, yawning, runny nose
- 24-48 hours: Escalation — insomnia, diarrhea, nausea, vomiting, abdominal cramps, dilated pupils
- 48-72 hours: Peak severity — intense cravings, body aches, goosebumps, rapid heartbeat
- 5-7 days: Acute symptoms begin to subside
- 1-2 weeks: Most physical symptoms resolve
Long-acting opioids (methadone, ER morphine)
- 24-48 hours: Delayed onset of symptoms
- 3-5 days: Symptoms escalate and peak
- 5-10 days: Peak and plateau of acute withdrawal
- 10-20 days: Gradual improvement of physical symptoms
- 2-3 weeks: Most acute symptoms resolve
Post-Acute Withdrawal Syndrome (PAWS)
After acute withdrawal resolves, many people experience Post-Acute Withdrawal Syndrome (PAWS) — a set of prolonged symptoms including anxiety, depression, insomnia, fatigue, difficulty concentrating, and mood swings that can persist for weeks to months. PAWS is the leading cause of relapse in the first year of recovery and is a key reason why ongoing treatment and support are essential after detox.
Why medical detox matters
While opioid withdrawal itself is rarely fatal, the extreme discomfort drives many people to relapse during detox — and relapse after a period of abstinence is when overdose risk is highest, because tolerance has decreased. Medically supervised detoxification uses medications like buprenorphine, clonidine, and comfort medications to manage symptoms safely, dramatically reducing relapse during the withdrawal period.
Medication-Assisted Treatment (MAT)
Medication-Assisted Treatment is the gold standard for opioid use disorder, combining FDA-approved medications with counseling and behavioral therapies. Research from NIDA shows MAT reduces opioid overdose deaths by more than 50%, decreases illicit opioid use, reduces criminal activity, improves social functioning, and increases treatment retention. Despite this evidence, fewer than 20% of people with OUD receive MAT — a treatment gap that costs tens of thousands of lives each year.
Buprenorphine (Suboxone)
Type: Partial opioid agonist
Buprenorphine activates opioid receptors just enough to prevent withdrawal and cravings without producing the intense euphoria of full agonists. It has a "ceiling effect," meaning higher doses do not increase effects — significantly reducing overdose risk. Suboxone combines buprenorphine with naloxone to deter misuse.
Setting: Can be prescribed by any licensed prescriber in office-based settings (OBOT), pharmacies, or telehealth.
Methadone
Type: Full opioid agonist
Methadone is a long-acting opioid that stabilizes brain chemistry, eliminates withdrawal symptoms, and blocks the euphoric effects of other opioids at proper doses. It has the longest track record of any MAT medication, with over 50 years of evidence supporting its effectiveness.
Setting: Must be dispensed daily at a certified Opioid Treatment Program (OTP/methadone clinic). Take-home doses earned over time with compliance.
Naltrexone (Vivitrol)
Type: Opioid antagonist (blocker)
Naltrexone completely blocks opioid receptors, preventing any opioid from producing effects. The extended-release injection (Vivitrol) is administered monthly and eliminates the need for daily medication adherence. Unlike buprenorphine and methadone, naltrexone has no abuse potential and is not a controlled substance.
Requirement: Patient must be fully detoxed (7-14 days opioid-free) before starting naltrexone to avoid precipitated withdrawal.
MAT medication comparison
The three FDA-approved MAT medications differ in mechanism, dispensing model, and patient fit. The table below summarizes the key distinctions:
| Medication | Type | DEA Schedule | Setting | Dispensing | Best for |
|---|---|---|---|---|---|
| Buprenorphine (Suboxone, Sublocade, Subutex, Zubsolv, Brixadi) | Partial agonist with ceiling effect | III | OBOT, telehealth, retail pharmacy | Take-home from day 1 (or monthly injection) | Most patients; rural areas; daily clinic not feasible |
| Methadone | Full mu-opioid agonist | II | OTP only (42 CFR Part 8) | Daily at clinic → take-home after 90 days | Severe OUD; prior buprenorphine failure; long-standing dependence |
| Naltrexone (Vivitrol) | Opioid antagonist (blocker) | Not controlled | Any prescriber; injection at clinic | Monthly IM injection (380 mg) | Highly motivated; post-detox (7-14 days opioid-free); no abuse potential desired |
All three are effective; the best choice is the one the patient will actually take consistently. Adherence, not pharmacology, is the dominant predictor of outcomes. Buprenorphine and methadone are first-line for active opioid use; naltrexone requires complete detox before initiation.
Types of Opioid Treatment Programs
OTP / Methadone Clinics
Opioid Treatment Programs are federally certified clinics that dispense methadone and provide comprehensive services including counseling, drug testing, and case management. Patients visit daily initially, earning take-home privileges over time.
OBOT (Office-Based Treatment)
Office-Based Opioid Treatment allows any licensed prescriber to treat OUD with buprenorphine in a standard medical office or via telehealth. This model dramatically increases access, especially in rural areas with no OTPs. Patients fill prescriptions at regular pharmacies.
Residential (inpatient) programs provide 24/7 structured care for 30-90 days. Best for severe OUD, polysubstance use, co-occurring mental health disorders, or patients who need separation from their environment. Most residential programs offer MAT as part of treatment.
IOP programs provide 9-20 hours of structured treatment per week while allowing patients to live at home. Combines group therapy, individual counseling, and MAT. Effective for moderate OUD or as a step-down from residential treatment.
Standard outpatient involves 1-2 sessions per week — typically individual therapy and/or group sessions combined with MAT. Suitable for mild to moderate OUD or as a long-term maintenance level of care after completing more intensive treatment.
Medical detox provides 3-7 days of supervised withdrawal management using medications to ease symptoms. Detox alone is not treatment — it must be followed by ongoing MAT and/or behavioral therapy. Detox without continued care has very high relapse rates.
Naloxone: The Overdose Reversal Medication
What naloxone does
Naloxone (brand name Narcan) is an opioid antagonist that rapidly reverses opioid overdose by displacing opioids from receptors in the brain. It restores normal breathing within 2-5 minutes in most cases. Naloxone has no effect on people who do not have opioids in their system and has virtually no abuse potential. Since 2023, Narcan nasal spray is available over the counter at pharmacies nationwide without a prescription.
How to use naloxone nasal spray
Using Narcan nasal spray requires no medical training:
- Peel back the package and remove the device
- Tilt the person's head back and insert the nozzle into one nostril
- Press the plunger firmly to deliver the full dose
- If no response in 2-3 minutes, administer a second dose in the other nostril
- Continue rescue breathing and call 911 — naloxone wears off in 30-90 minutes, and the person may stop breathing again
Where to get naloxone for free
Many harm reduction organizations, health departments, and community pharmacies distribute naloxone for free or at low cost. SAMHSA's Opioid Overdose Prevention Toolkit and state naloxone access programs provide resources. Most states have standing orders allowing pharmacists to dispense naloxone without an individual prescription. If you or someone you know uses opioids, carrying naloxone can save a life.
Frequently Asked Questions About Opioid Treatment
What is medication-assisted treatment (MAT) for opioid addiction?
Medication-Assisted Treatment (MAT) combines FDA-approved medications — methadone, buprenorphine (Suboxone), or naltrexone (Vivitrol) — with counseling and behavioral therapies. These medications reduce cravings, prevent withdrawal symptoms, and normalize brain chemistry, allowing people to focus on recovery. MAT is the most effective treatment for opioid use disorder: it reduces overdose deaths by more than 50%, decreases illicit drug use, and improves treatment retention rates (NIDA).
How long does opioid withdrawal last?
The withdrawal timeline depends on the opioid used. Short-acting opioids like heroin and oxycodone cause symptoms within 6-12 hours that peak at 48-72 hours and subside over 5-7 days. Long-acting opioids like methadone produce delayed symptoms starting at 24-48 hours, peaking at 3-5 days, and lasting up to 2-3 weeks. Post-acute withdrawal symptoms (PAWS) — including anxiety, insomnia, and mood instability — may persist for weeks to months after acute withdrawal resolves.
Is buprenorphine (Suboxone) just replacing one addiction with another?
No — this is one of the most harmful misconceptions in addiction medicine. Buprenorphine is a partial opioid agonist prescribed at stable, controlled doses as part of comprehensive treatment. It does not produce euphoria when taken as directed, eliminates cravings, prevents withdrawal, and allows people to function normally — work, care for families, and rebuild their lives. Taking buprenorphine for OUD is no different than taking insulin for diabetes: it is evidence-based medication for a chronic medical condition.
What should I look for in an opioid treatment center?
Look for centers offering MAT options (buprenorphine, methadone, and/or naltrexone), accreditation from CARF or The Joint Commission, licensed medical staff experienced in addiction medicine, comprehensive assessment with individualized treatment plans, evidence-based therapies (CBT, contingency management), family support services, and strong aftercare planning. Verify they accept your insurance and offer the appropriate level of care for your situation.
Can I work while in opioid treatment?
Yes, especially with outpatient MAT programs. Outpatient treatment — including OBOT (office-based buprenorphine) and standard outpatient counseling — allows you to maintain work, family, and social responsibilities while receiving care. Intensive Outpatient Programs (IOP) typically meet 9-20 hours per week and can often be scheduled around work. Many employers are required to support recovery under the ADA and FMLA. Residential treatment requires time away but provides the most intensive support for severe cases.
What is fentanyl and why is it so dangerous?
Fentanyl is a fully synthetic opioid that is 50-100 times more potent than morphine. A lethal dose is just 2 milligrams. It is increasingly found in the illicit drug supply, mixed into heroin, cocaine, methamphetamine, and counterfeit prescription pills — often without the user's knowledge. Fentanyl is now responsible for roughly 75% of all opioid overdose deaths in the United States. Treatment for fentanyl addiction typically requires MAT (often at higher buprenorphine or methadone doses), naloxone training, and comprehensive behavioral support.
How long does MAT treatment last?
There is no fixed duration for MAT — treatment length should be individualized. Research consistently shows that longer treatment produces better outcomes. The American Society of Addiction Medicine (ASAM) recommends a minimum of one year of MAT, and many addiction specialists recommend indefinite maintenance for people with severe OUD, as the risk of fatal overdose is highest in the period after discontinuing MAT. The decision to taper off medication should be made collaboratively with a treatment provider when the patient is stable, has strong support systems, and is not facing major life stressors.
Is fentanyl in the drug supply near me?
Almost certainly yes. Fentanyl has been detected in the illicit drug supply in all 50 states. It is routinely found in heroin, counterfeit prescription pills (especially fake oxycodone M30s, Xanax, and Adderall), cocaine, and methamphetamine. DEA lab testing shows that 7 out of 10 counterfeit pills seized contain a potentially lethal dose of fentanyl. Fentanyl test strips — which can detect fentanyl before use — are available for free from many harm reduction organizations, health departments, and community pharmacies. The safest assumption is that any illicit substance may contain fentanyl.
Medical Review and Sources
Trusted Resources
Substance Abuse and Mental Health Services Administration
Federal agency providing information, resources, and treatment locator for substance abuse and mental health.
Helpline: 1-800-662-4357
National Institute on Drug Abuse
NIH institute advancing science on drug use and addiction causes, consequences, and treatment.
National Institute on Alcohol Abuse and Alcoholism
NIH institute supporting research on alcohol's impact on health and providing treatment resources.
Ready To Start Opioid Treatment?
Opioid addiction is a medical condition — not a moral failure. Medication-assisted treatment saves lives. Speak with a specialist who can help you find the right MAT program, detox center, or residential facility — 100% free and confidential, available 24/7.
Browse opioid addiction programs in states with the most treatment options.
Related conditions, treatment approaches, and levels of care.